US Biomax, Inc.

BR243

Breast cancer and adjacent normal tissue array, 6 cases/24 cores, replacing BR241

Microarray Panel:Breast invasive ductal carcinoma tissue microarray with adjacent normal breast tissue, containing 6 cases of breast invasive ductal carcinoma, quadruple cores per case
Cores:24
Cases:6
Layout:8 cols × 3 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678
A Bre Bre Bre Bre Bre Bre Bre Bre
B Bre Bre Bre Bre Bre Bre Bre Bre
C Bre Bre Bre Bre Bre Bre Bre Bre
Legend: Bre - Breast

- Malignant tumor, - Malignant tumor (stage I-II), - Malignant tumor (stage II), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 40 Breast Invasive ductal carcinoma 2 II T2N1M0 Malignant
A2 2 F 40 Breast Invasive ductal carcinoma 2 II T2N1M0 Malignant
A3 3 F 40 Breast Cancer adjacent normal breast tissue T2N1M0 NAT
A4 4 F 40 Breast Cancer adjacent normal breast tissue T2N1M0 NAT
A5 5 F 44 Breast Invasive ductal carcinoma (sparse carcinomatous embolia) T2N0M0 Malignant
A6 6 F 44 Breast Invasive ductal carcinoma 2 II T2N0M0 Malignant
A7 7 F 44 Breast Cancer adjacent normal breast tissue (adenosis) T2N0M0 NAT
A8 8 F 44 Breast Cancer adjacent normal breast tissue (adenosis) T2N0M0 NAT
B1 9 F 31 Breast Invasive ductal carcinoma 2 II T2N0M0 Malignant
B2 10 F 31 Breast Invasive ductal carcinoma 2 II T2N0M0 Malignant
B3 11 F 31 Breast Cancer adjacent normal breast tissue (adenosis) T2N0M0 NAT
B4 12 F 31 Breast Cancer adjacent normal breast tissue (adenosis) T2N0M0 NAT
B5 13 F 41 Breast Invasive ductal carcinoma 2 II T2N2M0 Malignant
B6 14 F 41 Breast Invasive ductal carcinoma 2 II T2N2M0 Malignant
B7 15 F 41 Breast Cancer adjacent normal breast tissue T2N2M0 NAT
B8 16 F 41 Breast Cancer adjacent normal breast tissue T2N2M0 NAT
C1 17 F 52 Breast Invasive ductal carcinoma 1–2 I-II T2N1M0 Malignant
C2 18 F 52 Breast Invasive ductal carcinoma 1–2 I-II T2N1M0 Malignant
C3 19 F 52 Breast Cancer adjacent normal breast tissue T2N1M0 NAT
C4 20 F 52 Breast Cancer adjacent normal breast tissue T2N1M0 NAT
C5 21 F 51 Breast Invasive ductal carcinoma 2 II T2N0M0 Malignant
C6 22 F 51 Breast Invasive ductal carcinoma 1–2 I-II T2N0M0 Malignant
C7 23 F 51 Breast Cancer adjacent normal breast tissue (sparse adenosis) T2N0M0 NAT
C8 24 F 51 Breast Cancer adjacent normal breast tissue (adenosis) T2N0M0 NAT

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: